<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="10127" OLDID="15648" TOPICS="NO">
<DATE>26-MAR-1987 15:45:37.32</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f2428 reute
d f BC-IMS-INTERNATIONAL-SPI   03-26 0103</UNKNOWN>
<TEXT> 
<TITLE>IMS INTERNATIONAL SPINS-OFF UNIT IN OFFERING</TITLE>
<DATELINE>    NEW YORK, March 26 - </DATELINE><BODY>&lt;IMS International Inc&gt; said its
Applied Bioscience International Inc &lt;APBI&gt; unit is making an
initial public offering of three mln shares of common stock at
15 dlrs a share.
    The offering, through a syndicate managed by Shearson
Lehman Bros Inc and L.F. Rothschild Unterberg Towbin Inc,
consists of IMS's entire holdings.
    The unit is a toxicological testing company that has
laboratories in the U.S. and U.K. It is parent to Bio/dynamics
Inc and Life Science Research Ltd, which were previously the
Life Sciences division of IMS International.
 Reuter
 </BODY></TEXT>
</REUTERS>